-+ 0.00%
-+ 0.00%
-+ 0.00%

Nanologica Names Mark Quick CEO

PUBT·10/23/2026 05:40:21
Listen to the news
Nanologica Names Mark Quick CEO
  • Nanologica appointed Mark Quick as its next group CEO to lead its updated growth strategy.
  • Quick is a partner at Flerie, with previous senior roles at Recipharm spanning commercialization, international expansion, pharmaceutical manufacturing and acquisitions.
  • Outgoing CEO Andreas Bhagwani will become general manager of the purification and separation business, focusing on commercial expansion.
  • Axel Elner will join as group CFO in mid-November.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nanologica AB published the original content used to generate this news brief on October 23, 2026, and is solely responsible for the information contained therein.